IM Cannabis Investor Relations Material
Latest events
Q1 2025
IM Cannabis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IM Cannabis Corp
Access all reports
IM Cannabis Corp is a multinational cannabis company engaged in the cultivation, production, and distribution of medical and recreational cannabis products. The company operates across several regions, including Israel, Germany, and Canada, offering a range of cannabis products such as dried flower, oils, and extracts. IM Cannabis focuses on providing high-quality, pharmaceutical-grade cannabis for medical patients as well as premium products for the recreational market. The company is headquartered in Tel Aviv, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
IMCC
Country
🇺🇸 United States